A Dose Escalation Study to Investigate the Safety, Pharmacokinetics (PK), Pharmacodynamics (PD), and Clinical Activity of GSK525762 Plus Trametinib in Subjects With Solid Tumors
Clinical trial NCT03266159 · WITHDRAWN
Trial details
- NCT number
- NCT03266159
- Sponsor
- GlaxoSmithKline
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-27
- Primary completion
- 2020-08-19
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.